Informação sobre produto
Nome:
Cilostazol - USP
Sinónimos:
- 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
- 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-
- 6-[4-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
- 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone
- 6-[4-(1-Cyclohexyl-5-Tetrazolyl)Butoxy]-1,2,3,4-Tetrahydro-2-Oxoquinolinone
- 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
- Cilostazole
- Opc 13013
- Opc 21
- Pletaal
- Ver mais sinónimos
- Pletal
- Cilostazol
Descrição:
Cilostazol is a drug used to treat congestive heart failure and intermittent claudication, which is pain caused by poor blood circulation in the legs. It is a controlled-release preparation that is designed to release cilostazol gradually over 12 hours. Cilostazol has been shown to be effective against neuronal death, which may be due to its ability to inhibit cyclic nucleotide phosphodiesterases. The drug also has been shown to increase the production of growth factor-β1 (GF-β1) in vitro models. Cilostazol's effect on the biochemical properties of erythrocytes and platelets have been studied in vivo models.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
369.46 g/mol
Fórmula:
C20H27N5O2
Pureza:
Min. 95%
InChI:
InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)
Chave InChI:
InChIKey=RRGUKTPIGVIEKM-UHFFFAOYSA-N
SMILES:
O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
